Fig. 2.
Net cost of PCSK9 inhibitor therapy, based on 61 patients’ cost history, assuming a 50 % reduction in CVD events on PCSK9 inhibitor therapy
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.